From J&J on­col­o­gy chief to tiny biotech start­up CEO? Serge Messer­lian talks about his big ca­reer change­up

4 years ago
People

Ho­log­ic inks glob­al women’s ten­nis spon­sor­ship in lat­est sports tie-in fol­low­ing its Su­per Bowl de­but

4 years ago
Pharma
Marketing

FDA res­ur­rects pro­pos­al to gauge qual­i­ty met­rics in phar­ma man­u­fac­tur­ing

4 years ago
FDA+
Manufacturing

Sanofi CEO Paul Hud­son sketch­es a $1B-plus in­vest­ment on its new mR­NA cen­ter

4 years ago
Pharma
Manufacturing

Am­gen gets the dirt fly­ing on its new $550M man­u­fac­tur­ing site as phar­ma build­ing booms in NC

4 years ago
Pharma
Manufacturing

Mar­ket­ingRx roundup: Lund­beck’s Vyep­ti joins mi­graine TV ad bat­tle; Pfiz­er de­buts Covid treat­ment TV ad

4 years ago
Pharma
Marketing

Phar­ma col­ors and mar­ket­ing: Typ­i­cal­ly ‘awash in blue,’ new­er brand up­dates adopt bold hues

4 years ago
Pharma
Marketing

'Test to treat': Biden launch­es new Covid pill ini­tia­tive amid out­stand­ing ques­tions on ac­cess

4 years ago
Pharma
Coronavirus

Kur­ma scores $175M in first clos­ing of biotech/healthtech fund — the VC's largest yet

4 years ago
Financing

Sher­lock, Feng Zhang's CRISPR di­ag­nos­tic out­fit, grabs $80M to go be­yond Covid-19

4 years ago
Financing
Diagnostics

BioN­Tech and Re­gen­eron ex­pand their can­cer part­ner­ship, push­ing new Lib­tayo com­bo in­to NSCLC

4 years ago
Deals

‘We would have no choice’: Bio­gen CEO Vounatsos isn’t about to let go of the bud­get axe — un­less they break ...

4 years ago
Bioregnum

With in­vest­ment from Al­loy, Boston pep­tide man­u­fac­tur­er an­nounces Se­ries A

4 years ago
Financing
Pharma

Over­haul­ing FDA's ac­cel­er­at­ed ap­proval path­way: Key House com­mit­tee chair pens new bill

4 years ago
FDA+

An AI biotech emerges from stealth promis­ing drugs 'on de­mand.' What will that look like, and is it even pos­si­ble?

4 years ago
Financing
Startups

No­var­tis takes a gam­ble on Voy­ager's new AAV tech, inks $1.7B gene ther­a­py dis­cov­ery pact

4 years ago
Deals
Cell/Gene Tx

So, just how much are those CRISPR patents ac­tu­al­ly worth?

4 years ago
Deals
Cell/Gene Tx

Af­ter near­ly two years of crit­i­cism from ac­tivists and White House, Mod­er­na un­veils a new plan for glob­al health

4 years ago
Coronavirus
Manufacturing

J&J re­grets pay­ing for study that in­ject­ed in­car­cer­at­ed Black men with as­bestos — re­port

4 years ago
Pharma

Months af­ter big fi­nanc­ing round, Touch­light signs sup­ply agree­ment for Ver­same­b's pipeline

4 years ago
Pharma
Manufacturing

Big Phar­ma vet­er­an Karin Shana­han re­unites with Bris­tol My­er­s' sup­ply team af­ter 12 years apart

4 years ago
R&D

Af­ter 16 years, BM­S' megablock­buster can­cer drug fi­nal­ly runs in­to its first gener­ic com­pe­ti­tion

4 years ago
Pharma

En­do’s first DTC cam­paign for Qwo tack­les cel­lulite by en­cour­ag­ing women to think ‘Butt First’  

4 years ago
Pharma
Marketing

Dig­i­tal tech boost­ed Pfiz­er com­mer­cial, R&D gains dur­ing Covid — and there’s no go­ing back, ex­ecs say

4 years ago
Pharma
Marketing
First page Previous page 580581582583584585586 Next page Last page
A service from the Financial Times